[Studies on tissue schizonticide of malaria parasite: synthesis of 2-substituted benzyloxy (or methoxy)-5-substituted phenoxy analogues of primaquine].
2-Chloro-6-methoxy-8-nitroquinoline was reacted with substituted benzyl alcohols (or sodium methanol) and then brominated to give 2-substituted benzyloxy-6-methoxy- and 2,6-dimethoxy-5-bromo-8-nitroquinolines (compounds 5-8 in Table 1). These products were condensed with substituted phenols to form corresponding 5-substituted phenoxy compounds (9-19 in Tables 1 and 2) which were subsequently reduced to afford 2-substituted benzyloxy-6-methoxy- and 2,6-dimethoxy-5-substituted phenoxy-8-aminoquinolines (20-28, 47 and 48 in Tables 3 and 6). Condensation with 4-bromophthalimidopentane yielded corresponding 8-(4-phthalimido-1-methylbutyl)aminoquinolines (29-37, 49 and 50 in Tables 4 and 6) which were subsequently treated with hydrazine hydrate to give 2-substituted benzyloxy-6-methoxy- and 2,6-dimethoxy-5-substituted phenoxy-8-(4-amino-1-methylbutyl)amino-quinolines, compounds III and IV (38-46, 51 and 52 in Tables 5 and 6), the analogues of primaquine. Compounds III and IV were tested against Plasmodium yoenii in mice infected with sporozoites. The parasitaemia of 80% and 90% of tested mice was negative at an oral single dose of 100 mg/kg of compounds 39 and 45, respectively. The results of further studies on compound 45 showed that the parasitaemia of 80% of mice was negative at a single dose of 20 mg/kg, and the acute toxicity in mice was less than that of primaquine.
Zheng
X Y
XY
Institute of Parasitic Diseases, Chinese Academy of Preventive Medicine, Shanghai.
Chen
C
C
Gao
F H
FH
D000818:Animals; D000962:Antimalarials / Q000138:chemical synthesis* / Q000494:pharmacology; D008288:Malaria / Q000188:drug therapy*; D051379:Mice; D015394:Molecular Structure; D010967:Plasmodium yoelii / Q000187:drug effects*; D011319:Primaquine / Q000031:analogs & derivatives* / Q000138:chemical synthesis* / Q000494:pharmacology
D000962:Antimalarials; D011319:Primaquine